CCB(CCB)
CCB
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $621M | $753M |
| Low | $551M | $668M |
| High | $662M | $802M |
| EBITDA Avg | $113M | $137M |
| Low | $100M | $122M |
| High | $121M | $146M |
| EBIT Avg | $108M | $130M |
| Low | $95M | $116M |
| High | $115M | $139M |
| Net Income Avg | $30M | $97M |
| Low | $30M | $92M |
| High | $31M | $103M |
| EPS Avg | $1.96 | $6.32 |
| Low | $1.91 | $5.98 |
| High | $2.01 | $6.67 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $158M | $168M | $189M | $199M | $210M | $219M |
| Low | $143M | $152M | $171M | $180M | $190M | $199M |
| High | $167M | $178M | $200M | $211M | $222M | $232M |
| EBITDA Avg | $29M | $31M | $34M | $36M | $38M | $40M |
| Low | $26M | $28M | $31M | $33M | $35M | $36M |
| High | $30M | $32M | $37M | $38M | $40M | $42M |
| EBIT Avg | $27M | $29M | $33M | $34M | $36M | $38M |
| Low | $25M | $26M | $30M | $31M | $33M | $34M |
| High | $29M | $31M | $35M | $37M | $38M | $40M |
| Net Income Avg | $16M | $19M | $22M | $24M | $27M | $29M |
| Low | $14M | $17M | $19M | $21M | $23M | $25M |
| High | $18M | $20M | $23M | $26M | $29M | $31M |
| EPS Avg | $1.06 | $1.23 | $1.39 | $1.55 | $1.72 | $1.87 |
| Low | $0.93 | $1.08 | $1.22 | $1.36 | $1.51 | $1.64 |
| High | $1.18 | $1.32 | $1.50 | $1.67 | $1.85 | $2.02 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |